0.8069
2.14%
0.0169
시장 영업 전:
.84
0.0331
+4.10%
전일 마감가:
$0.79
열려 있는:
$0.79
하루 거래량:
1.10M
Relative Volume:
1.07
시가총액:
$42.72M
수익:
$114.73M
순이익/손실:
$-140.94M
주가수익비율:
-0.2924
EPS:
-2.76
순현금흐름:
$-126.18M
1주 성능:
-0.64%
1개월 성능:
-33.31%
6개월 성능:
-79.15%
1년 성능:
-77.62%
아웃셋 메디컬 Stock (OM) Company Profile
명칭
Outset Medical Inc
전화
669-231-8200
주소
3052 ORCHARD DRIVE, SAN JOSE
OM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
0.8069 | 42.72M | 114.73M | -140.94M | -126.18M | -2.76 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
아웃셋 메디컬 Stock (OM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-08-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2024-06-21 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2024-04-08 | 개시 | BTIG Research | Buy |
2024-04-05 | 업그레이드 | CL King | Neutral → Buy |
2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
2023-08-17 | 개시 | CL King | Neutral |
2022-11-11 | 개시 | RBC Capital Mkts | Outperform |
2022-07-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2022-03-02 | 재개 | BofA Securities | Buy |
2022-02-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2021-08-18 | 개시 | Cowen | Outperform |
2021-04-19 | 개시 | Wells Fargo | Overweight |
2020-12-16 | 개시 | Oppenheimer | Perform |
2020-10-12 | 개시 | Barclays | Overweight |
2020-10-12 | 개시 | BofA Securities | Buy |
2020-10-12 | 개시 | Goldman | Buy |
2020-10-12 | 개시 | Morgan Stanley | Equal-Weight |
2020-10-12 | 개시 | SVB Leerink | Mkt Perform |
2020-10-12 | 개시 | Stifel | Buy |
모두보기
아웃셋 메디컬 주식(OM)의 최신 뉴스
OM Investors Have Opportunity to Lead Outset Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Shareholders that lost money on Outset Medical, Inc.(OM) Urged t - GuruFocus.com
OM (Outset Medical) EV-to-EBITDA : -0.61 (As of Jan. 14, 2025) - GuruFocus.com
Outset Medical CEO Leslie Trigg sells $26,913 in common stock By Investing.com - Investing.com Australia
Outset Medical general counsel sells $16,598 in stock By Investing.com - Investing.com Australia
Outset Medical's SVP sells shares worth $12,158 By Investing.com - Investing.com Australia
Outset medical CFO Ahmed Nabeel sells stock worth $23,515 By Investing.com - Investing.com Australia
Outset Medical CEO Leslie Trigg sells $26,913 in common stock - Investing.com
Outset medical CFO Ahmed Nabeel sells stock worth $23,515 - Investing.com
Outset Medical's SVP sells shares worth $12,158 - Investing.com
Outset Medical general counsel sells $16,598 in stock - Investing.com India
Durable Capital Partners LP Acquires Significant Stake in Outset Medical Inc - GuruFocus.com
Outset Medical issues Series A Preferred Stock, repays senior credit By Investing.com - Investing.com Australia
Outset Medical issues Series A Preferred Stock, repays senior credit - Investing.com
Outset Medical Strengthens Financial Position with Key Moves - TipRanks
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
Leslie Trigg Sells 10,227 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock - MarketBeat
Outset Medical SVP Marc Nash sells $928 in stock By Investing.com - Investing.com Australia
Outset Medical chair and CEO sells $13,192 in stock - Investing.com India
Outset Medical general counsel sells shares worth $2,027 - Investing.com
Outset Medical chair and CEO sells $13,192 in stock By Investing.com - Investing.com Canada
Outset Medical SVP Marc Nash sells $928 in stock - Investing.com
Outset Medical CFO sells shares worth $2,367 - Investing.com
Outset Medical CFO sells shares worth $2,367 By Investing.com - Investing.com UK
Outset Medical's SWOT analysis: stock poised for growth amid transformation - Investing.com
Outset Medical to pay down debt after raising nearly $300M - MedTech Dive
Royal Bank of Canada Reaffirms Sector Perform Rating for Outset Medical (NASDAQ:OM) - MarketBeat
Latham Advises on Outset Medical’s US$169 Million Private Placement Financing - Latham & Watkins LLP
Outset Medical Secures New Financing and Debt Facility - TipRanks
Outset Medical announces $169M financing - Mass Device
Outset Medical announces $169 million private placement - MSN
Outset Medical announces $169M private placement financing - TipRanks
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors - The Manila Times
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and - The Bakersfield Californian
Outset Medical Secures $294M Financing Package, Posts Strong 2024 Revenue Growth - StockTitan
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys Before Sept. 6th Deadline in Securities Fraud Class Action - AccessWire
A Piece Of The Puzzle Missing From Outset Medical, Inc.'s (NASDAQ:OM) 44% Share Price Climb - Simply Wall St
Outset Medical, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your RightsOM - The Eastern Progress Online
Outset Medical, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Outset Medical, Inc. - The Eastern Progress Online
Fmr LLC Sells 2,923,144 Shares of Outset Medical, Inc. (NASDAQ:OM) - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Shares Sold by Fmr LLC - Defense World
아웃셋 메디컬 (OM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):